Date: 23-Oct-2019

GSK Pharma closes Q2 revenue up 8 pc at Rs 873 crore

GlaxoSmithKline (GSK) Pharmaceuticals on Tuesday reported revenue for the quarter ended September 30 at Rs 873 crore with a year-on-year growth of 8 per cent. Profit after tax (PAT) including exceptional items came at Rs 503 crore, clocking a growth of 399 per cent. Exceptional items recognised in the quarter include divestment of the company's land at Thane for a net consideration of Rs 552 crore.